Scientists have progressed from merely provoking an anti-cancer immune response to designing it ...

A new advance may make it possible to use off-the-shelf CAR T cells provided by healthy donors. The new approach studied in mice equipped CAR T cells with the viral protein Nef.

A recent study has uncovered key insights into the differing tumour rejection behaviours of chimeric antigen receptor T cells ...

(Top right) Antigen escape: tumor cells can downregulate or lose the expression of the targeted antigen ... Universal CAR-T cells within this group are engineered to avoid immune rejection and GvHD, ...

NKure Therapeutics, a Bengaluru-based cell and gene therapy start-up, is trying to address this problem by working on ...

Everyone experiences rejection at one time or another. It's a normal part of life. However, for people with rejection sensitive dysphoria (RSD), even mild rejection can lead to intense and ...

(NASDAQ: CRGX), a clinical-stage biotechnology company positioned to advance next-generation, potentially curative cell therapies for cancer patients ... immune-based rejection of allogeneic ...

Immune system cells recognise that antigen as being “non-self”/foreign and begin an immune response. There is high variability in the gene responsible for encoding MHC I proteins so no two humans are ...

Mazed appealed from the rejection of claims 85 and 87 of his ... an origami nanostructure for binding a synthetic peptide tumor antigen as taught by [the prior art] with a reasonable expectation ...